查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600933

人源類器官市場：按產品、可用性、應用和最終用戶分類 - 2025-2030 年全球預測

Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人源類器官市場規模預計為5.9484億美元，預計2024年將達到7.0334億美元，複合年成長率為19.94%，到2030年將達到21.2491億美元。

人源類器官是幹細胞源性器官的3D微型化版本，模仿真實器官的功能和結構。這種尖端模型處於生物學和技術的交叉點，在人類疾病理解、藥物開發和個人化醫療方面帶來了前所未有的進步。對人源類器官的需求不斷成長，因為它們能夠提供比傳統 2D 培養更準確的體外模型，可用於治療複雜的人類特異性感染疾病、癌症和神經退化性疾病的研究。從那時起，它的應用範圍擴大到包括製藥、生物技術工業、學術研究和再生醫學。主要最終用戶包括製藥商、學術研究機構和醫院。

主要市場統計
基準年[2023] 5.9484億美元
預測年份 [2024] 7.0334億美元
預測年份 [2030] 21.2491億美元
複合年成長率（%） 19.94%

該市場的成長受到幹細胞技術持續進步、個人化醫療需求不斷成長以及政府資助研究舉措的強烈影響。此外，COVID-19 大流行凸顯了需要更好的人類特異性模型來研究病毒感染，從而使市場受益。類器官技術在慢性病建模、個人化藥物篩檢和毒性測試方面的擴展存在著巨大的商機，為生物技術公司和學術機構之間的策略聯盟鋪平了道路。

然而，開發成本高、維持 3D 培養的技術複雜性、使用幹細胞的倫理考量以及缺乏標準化通訊協定等挑戰正在阻礙市場擴張。透過全行業合作和監管發展來解決這些限制可以促進成長。基於 CRISPR 的基因編輯、晶片類器官平台以及與人工智慧整合進行巨量資料分析等創新代表了研究和開發的肥沃領域。在快速的技術進步和策略夥伴關係關係的推動下，市場的本質仍然是動態和競爭的。公司應專注於確保類器官可重複性和擴充性的技術，並加強多學科團隊之間的合作，以利用不同的專業知識，從而加強其市場地位並利用新的機會。

市場動態：揭示快速發展的人類類器官市場的關鍵市場洞察

供需的動態交互作用正在改變人源類器官市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 迫切需要開發動物實驗模型的替代品
    • 越來越關注改善疾病模型和藥物發現
  • 市場限制因素
    • 缺乏熟練勞動力
  • 市場機會
    • 人源類器官開發的研究經費與資本投資大幅增加
    • 將人源類器官應用於生物計算的可能性
  • 市場挑戰
    • 當前類器官技術的問題

波特的五力：駕馭人類類器官市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對人源類器官市場的影響

外部宏觀環境因素在塑造人源類器官市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人源類器官市場的競爭狀況

對人源類器官市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣人源類器官市場供應商的績效評估

FPNV定位矩陣是評估人源類器官市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 迫切需要開發替代動物實驗模型。
      • 越來越關注改善疾病模型和發現新藥
    • 抑制因素
      • 缺乏熟練勞動力
    • 機會
      • 人源類器官開發的研究經費與資本投資大幅增加
      • 人源類器官在生物計算的潛在應用
    • 任務
      • 與當前類器官技術相關的問題
  • 市場區隔分析
    • 產品：發現肝臟類器官在藥理學和毒理學研究中的關鍵作用
    • 脂溶性：增加人源類器官在藥物毒性和功效測試中的採用，以改善病患照護和安全
    • 應用：增加使用可客製化產品，使研究人員能夠客製化類器官培養物以滿足特定需求
    • 最終用戶：學術和研究機構對人源類器官的需求日益成長，以識別新的藥物標靶並了解疾病進展。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 人類源性類器官市場：依產品

  • 冒號
  • 心
  • 腎
  • 肝
  • 胰臟

第7章 人源類器官市場：使用性別

  • 可客製化產品
  • 即用型產品

第8章 人源類器官市場：依應用分類

  • 發育生物學
  • 疾病病理學
  • 藥物毒性及藥效測試
  • 個人化醫療
  • 再生醫學

第 9 章 人類源性類器官市場：依最終使用者分類

  • 學術研究所
  • 臨床研究所
  • 製藥和生物技術公司

第10章美洲人源類器官市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區人源類器官市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的人源類器官市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Sinai Health 對培養類器官的 1000 萬美元投資將改變疾病調查和藥物發現
    • 合作夥伴關係推進藥物開發中的心臟安全測試：ATCC 和 Tissue Dynamics 合作
    • 利用人類肝類器官技術提高藥物安全性：CuSTOM 與丹納赫公司之間的創新合作
    • 使用幹細胞衍生的腦類器官進行神經退化性疾病建模的革命性進展
    • 透過開放用於下一代疾病建模的最先進的類器官設施來推進精準醫學
    • 羅氏的革命性推出：人類生物學研究所利用類器官技術推進醫學研究
    • 羅氏在巴塞爾建立人類生物學研究所，透過研究類器官和人體模型系統徹底改變藥物發現
    • 國家科學基金會工程辦公室的新前沿：從類器官智慧到客製化學習
    • Molecular Devices 與 HUB Organoids 合作推進 3D 生物技術
    • 創新藥物發現：Molecular Devices 與 HUB Organoids 建立策略夥伴關係

公司名單

  • 3Dnamics Inc.
  • AIVITA Biomedical, Inc.
  • BICO Group AB
  • Bio-Techne Corporation
  • BioIVT LLC
  • BrainZell
  • Cannex Scientific, Inc.
  • CN Bio Innovations Limited
  • Corning Incorporated
  • DefiniGEN Limited
  • F. Hoffmann-La Roche Ltd.
  • HeartBeat.bio AG
  • Herophilus
  • HUB Organoids BV
  • InSphero AG
  • Kirkstall Ltd.
  • Merck KGaA
  • Miltenyi Biotec BV & CO. KG
  • Mimetas BV
  • Molecular Devices, LLC by Danaher Corporation
  • Neurxstem Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • PerkinElmer, Inc.
  • PRIMACYT Cell Culture Technology GmbH
  • Rumi Scientific, Inc.
  • STEMCELL Technologies Canada Inc.
  • SUN bioscience SA.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-DD6333AE58DD

The Human Organoids Market was valued at USD 594.84 million in 2023, expected to reach USD 703.34 million in 2024, and is projected to grow at a CAGR of 19.94%, to USD 2,124.91 million by 2030.

Human organoids are three-dimensional, miniaturized versions of organs derived from stem cells, mimicking actual organ function and structure. These cutting-edge models represent an intersection of biology and technology, offering unprecedented advancements in understanding human diseases, drug development, and personalized medicine. The increasing necessity for human organoids stems from their capability to provide more accurate in vitro models than traditional 2D cultures, aiding research into complex human-specific infections, cancer, and neurodegenerative diseases. Subsequently, their applications span pharmaceutical and biotechnology industries, academic research, and regenerative medicine. Key end-users include drug manufacturers, academic and research institutes, and hospitals.

KEY MARKET STATISTICS
Base Year [2023] USD 594.84 million
Estimated Year [2024] USD 703.34 million
Forecast Year [2030] USD 2,124.91 million
CAGR (%) 19.94%

The market's growth is strongly influenced by continuous advancements in stem cell technologies, increasing demand for personalized medicine, and government funding supporting research initiatives. Moreover, the COVID-19 pandemic underscored the demand for better human-specific models to study viral infections, benefiting the market. Profound opportunities exist in the expansion of organoid technology for chronic disease modeling, personalized drug screening, and toxicity testing, creating avenues for strategic collaborations between biotech firms and academic institutions.

Nevertheless, challenges such as high development costs, technical complexities in 3D culture maintenance, ethical considerations regarding stem cell usage, and a lack of standardized protocols hinder market expansion. Addressing these limitations through industry-wide collaborations and regulatory advancements could drive growth. Innovations including CRISPR-based genetic editing, organoid-on-a-chip platforms, and integration with artificial intelligence for big data analysis represent fertile areas for research and development. The nature of the market remains dynamic and competitive, driven by rapid technological advancements and strategic partnerships. Businesses should focus on investing in technology that ensures reproducibility and scalability of organoids, and on enhancing collaboration between multidisciplinary teams to leverage varied expertise, thereby reinforcing their market position and capitalizing on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Organoids Market

The Human Organoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High need for developing alternatives for animal testing models
    • Rising focus toward improving disease models and drug discovery
  • Market Restraints
    • Limited availability of skilled workforce
  • Market Opportunities
    • Significant increase in research funding and capital investments for the development of human organoids
    • Potential application of human organoids for biocomputing
  • Market Challenges
    • Issues related to current organoid technology

Porter's Five Forces: A Strategic Tool for Navigating the Human Organoids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Organoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Organoids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Organoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Organoids Market

A detailed market share analysis in the Human Organoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Organoids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Organoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Organoids Market, highlighting leading vendors and their innovative profiles. These include 3Dnamics Inc., AIVITA Biomedical, Inc., BICO Group AB, Bio-Techne Corporation, BioIVT LLC, BrainZell, Cannex Scientific, Inc., CN Bio Innovations Limited, Corning Incorporated, DefiniGEN Limited, F. Hoffmann-La Roche Ltd., HeartBeat.bio AG, Herophilus, HUB Organoids B.V., InSphero AG, Kirkstall Ltd., Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., PerkinElmer, Inc., PRIMACYT Cell Culture Technology GmbH, Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Holdings Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Organoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Colorectal, Heart, Kidney, Liver, and Pancreas.
  • Based on Usability, market is studied across Customizable Products and Ready to Use Products.
  • Based on Application, market is studied across Developmental Biology, Disease Pathology, Drug Toxicity & Efficacy Testing, Personalized Medicine, and Regenerative Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High need for developing alternatives for animal testing models
      • 5.1.1.2. Rising focus toward improving disease models and drug discovery
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled workforce
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant increase in research funding and capital investments for the development of human organoids
      • 5.1.3.2. Potential application of human organoids for biocomputing
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to current organoid technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging crucial role of liver organoids in pharmacology and toxicology studies
    • 5.2.2. Application: Increasing adoption of human organoids in drug toxicity and efficacy testing to improve patient care and safety
    • 5.2.3. Usability: Increasing usage of customizable products that allow researchers to tailor organoid cultures to their specific needs
    • 5.2.4. End-User: Rising need for human organoids across academic & research institutions for identifying novel drug targets and understanding disease progression
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Organoids Market, by Product

  • 6.1. Introduction
  • 6.2. Colorectal
  • 6.3. Heart
  • 6.4. Kidney
  • 6.5. Liver
  • 6.6. Pancreas

7. Human Organoids Market, by Usability

  • 7.1. Introduction
  • 7.2. Customizable Products
  • 7.3. Ready to Use Products

8. Human Organoids Market, by Application

  • 8.1. Introduction
  • 8.2. Developmental Biology
  • 8.3. Disease Pathology
  • 8.4. Drug Toxicity & Efficacy Testing
  • 8.5. Personalized Medicine
  • 8.6. Regenerative Medicine

9. Human Organoids Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Human Organoids Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Organoids Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Organoids Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Transforming Disease Research and Drug Discovery with Sinai Health's USD 10 Million Investment in Lab-Grown Organoids
    • 13.3.2. Partnership Advances Cardiac Safety Testing in Drug Development: ATCC and Tissue Dynamics Collaboration
    • 13.3.3. Advancing Drug Safety with Human Liver Organoid Technology: CuSTOM and Danaher Corporation's Innovative Collaboration
    • 13.3.4. Revolutionary Advancements in Neurodegenerative Disease Modeling Through Stem Cell-Derived Brain Organoids
    • 13.3.5. Advancing Precision Medicine with Launch of a State-of-the-Art Organoid Facility for Next-Generation Disease Modeling
    • 13.3.6. Roche's Revolutionary Launch: The Institute of Human Biology to Propel Medical Research with Organoid Technology
    • 13.3.7. Roche Launches Institute of Human Biology in Basel to Revolutionize Drug Discovery with Organoid and Human Model System Research
    • 13.3.8. New Frontiers by National Science Foundation's Directorate for Engineering: From Organoid Intelligence to Tailored Learning
    • 13.3.9. Molecular Devices Partners with HUB Organoids to Advance 3D Biology Technologies
    • 13.3.10. Innovating Drug Discovery: Molecular Devices and HUB Organoids Forge Strategic Partnership

Companies Mentioned

  • 1. 3Dnamics Inc.
  • 2. AIVITA Biomedical, Inc.
  • 3. BICO Group AB
  • 4. Bio-Techne Corporation
  • 5. BioIVT LLC
  • 6. BrainZell
  • 7. Cannex Scientific, Inc.
  • 8. CN Bio Innovations Limited
  • 9. Corning Incorporated
  • 10. DefiniGEN Limited
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. HeartBeat.bio AG
  • 13. Herophilus
  • 14. HUB Organoids B.V.
  • 15. InSphero AG
  • 16. Kirkstall Ltd.
  • 17. Merck KGaA
  • 18. Miltenyi Biotec B.V. & CO. KG
  • 19. Mimetas BV
  • 20. Molecular Devices, LLC by Danaher Corporation
  • 21. Neurxstem Inc.
  • 22. Organovo Holdings Inc.
  • 23. Pandorum Technologies Pvt. Ltd.
  • 24. PerkinElmer, Inc.
  • 25. PRIMACYT Cell Culture Technology GmbH
  • 26. Rumi Scientific, Inc.
  • 27. STEMCELL Technologies Canada Inc.
  • 28. SUN bioscience SA.
  • 29. Takara Holdings Inc.
  • 30. Thermo Fisher Scientific Inc.
  • 31. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. HUMAN ORGANOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN ORGANOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN ORGANOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. HUMAN ORGANOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY READY TO USE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DISEASE PATHOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 27. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 28. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 29. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 31. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 32. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 33. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 34. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 35. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 36. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 37. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 38. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 39. CANADA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 40. CANADA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 41. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 42. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 43. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 44. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 45. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 46. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 47. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 48. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 49. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 50. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 52. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 53. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 54. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 55. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 56. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 57. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 58. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 59. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 60. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 61. CHINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 62. CHINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 63. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 64. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 66. INDIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 67. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 68. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 70. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 71. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 72. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 73. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 74. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 75. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 76. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 77. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 78. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 79. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 82. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 83. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 84. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 85. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 86. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 87. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 88. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 90. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 91. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 92. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 93. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 94. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 95. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 96. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 97. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 98. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 99. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 102. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 103. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 104. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 110. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 111. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 112. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 113. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 114. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 115. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 116. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 117. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 118. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 119. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 120. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 121. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 122. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 123. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 124. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 125. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 126. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 127. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 128. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 129. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 130. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 131. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 132. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 133. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 134. ITALY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 135. ITALY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 136. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 137. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 138. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 139. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 140. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 141. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 142. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 143. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 144. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 145. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 146. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 147. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 148. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 149. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 150. POLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 151. POLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 152. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 153. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 154. QATAR HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 155. QATAR HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 156. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 157. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 158. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 159. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 160. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 163. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 164. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 165. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 166. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 167. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 168. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 169. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 170. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 171. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 172. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 173. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 175. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 176. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 177. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 178. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 179. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 180. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 181. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 182. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 183. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 184. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 185. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 187. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 188. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 189. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 190. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 191. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 192. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 193. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 194. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023